1. Home
  2. OCUL vs SEZL Comparison

OCUL vs SEZL Comparison

Compare OCUL & SEZL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • SEZL
  • Stock Information
  • Founded
  • OCUL 2006
  • SEZL 2016
  • Country
  • OCUL United States
  • SEZL United States
  • Employees
  • OCUL N/A
  • SEZL N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • SEZL Diversified Financial Services
  • Sector
  • OCUL Health Care
  • SEZL Finance
  • Exchange
  • OCUL Nasdaq
  • SEZL Nasdaq
  • Market Cap
  • OCUL 1.2B
  • SEZL N/A
  • IPO Year
  • OCUL 2014
  • SEZL N/A
  • Fundamental
  • Price
  • OCUL $7.34
  • SEZL $37.19
  • Analyst Decision
  • OCUL Strong Buy
  • SEZL Strong Buy
  • Analyst Count
  • OCUL 9
  • SEZL 2
  • Target Price
  • OCUL $16.22
  • SEZL $368.50
  • AVG Volume (30 Days)
  • OCUL 1.7M
  • SEZL 870.8K
  • Earning Date
  • OCUL 05-06-2025
  • SEZL 05-07-2025
  • Dividend Yield
  • OCUL N/A
  • SEZL N/A
  • EPS Growth
  • OCUL N/A
  • SEZL 950.40
  • EPS
  • OCUL N/A
  • SEZL 2.19
  • Revenue
  • OCUL $63,723,000.00
  • SEZL $271,127,890.00
  • Revenue This Year
  • OCUL $13.59
  • SEZL $33.01
  • Revenue Next Year
  • OCUL $13.88
  • SEZL $16.24
  • P/E Ratio
  • OCUL N/A
  • SEZL $16.99
  • Revenue Growth
  • OCUL 9.03
  • SEZL 70.14
  • 52 Week Low
  • OCUL $4.06
  • SEZL $6.73
  • 52 Week High
  • OCUL $11.78
  • SEZL $79.59
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 48.32
  • SEZL 44.57
  • Support Level
  • OCUL $7.36
  • SEZL $32.50
  • Resistance Level
  • OCUL $8.04
  • SEZL $43.83
  • Average True Range (ATR)
  • OCUL 0.49
  • SEZL 3.02
  • MACD
  • OCUL -0.06
  • SEZL -0.06
  • Stochastic Oscillator
  • OCUL 50.27
  • SEZL 41.39

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

Share on Social Networks: